Roles of receptor activity‐modifying protein 1 in angiogenesis and lymphangiogenesis during skin wound healing in mice
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Receptor activity‐modifying protein 1 (RAMP1) forms a complex with calcitonin receptor‐like receptor (CLR) to produce the receptor for calcitonin gene‐related peptide (CGRP). CGRP, a 37‐aa neuropeptide, is widely distributed in neuronal tissues and exerts its biological effects via CLR/RAMP1; however, the pathophysiological roles of CLR/RAMP1 remain to be clarified. To study the functions of CLR/RAMP1, we generated RAMP1‐knockout ( RAMP1 –/– ) mice. Compared with those of wild‐type (WT) mice, wound healing and wound‐induced angiogenesis were significantly suppressed in RAMP1 –/– mice, with reduced expression of vascular endothelial growth factor (VEGF)‐A. Formation of the lymphatic vessels that drain interstitial fluids was also suppressed in RAMP1 –/– mice, with reduced expression of VEGF‐C and VEGFR‐3 in wound granulation tissues. RAMP1 was expressed in endothelial cells (ECs) in the preexisting skin blood vessels, but was not observed in ECs in newly formed blood or lymphatic vessels. Macrophages in the wound granulation tissues expressed RAMP1 and produced substantial amounts of VEGF‐C in response to CGRP in vitro. RAMP1 –/– bone marrow chimeric mice showed delayed wound healing with reduced angiogenesis/lymphangiogenesis in wound granulation tissues. These findings suggest that RAMP1 plays a crucial role in wound healing and wound‐induced angiogenesis and lymphangiogenesis and that it is a promising target for controlling angiogenesis and lymphangiogenesis.—Kurashige, C., Hosono, K., Matsuda, H., Tsujikawa, K., Okamoto, H., Majima, M. Roles of receptor activity‐modifying protein 1 in angiogenesis and lymphangiogenesis during skin wound healing in mice. FASEB J. 28, 1237–1247 (2014). www.fasebj.org
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The study found that wound healing and wound-induced angiogenesis were significantly suppressed in Ramp1 KO mice in comparison to WT controls.”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [128]
In the citing paper
“Wound healing was also delayed in chimeric mice produced by transplantation of bone marrow from Ramp1 KO into WT mice, indicating a crucial role for hematopoietic cells recruited into the wound.”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [128]
Citations
Cites
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
Singer, A. J., & Clark, R. A. F. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411006 · Cited by 6,106
RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor
McLatchie, L. M., Fraser, N. J., Main, M. J., Wise, A., Brown, J., Thompson, N., Solari, R., Lee, M. G., & Foord, S. M. (1998) · Nature · doi:10.1038/30666 · Cited by 2,134 · cited 1×
“CGRP binds to CGRP receptors composed of RAMP1 and calcitonin receptor-like receptor (CLR) to modulate various functions, such as vasodilation and pain transmission (2, 3).”
BackgroundAmara, S. G., Jonas, V., Rosenfeld, M. G., Ong, E. S., & Evans, R. M. (1982) · Nature · doi:10.1038/298240a0 · Cited by 2,105
Adrenomedullin, a Multifunctional Regulatory Peptide*
Hinson, J. P., Kapas, S., & Smith, D. M. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.2.0396 · Cited by 752 · cited 1×
“CLR is a common receptor subunit for both CGRP and adrenomedullin (AM), a 52-aa peptide that shares some degree of homology with CGRP (5).”
BackgroundMukouyama, Y.-S., Shin, D., Britsch, S., Taniguchi, M., & Anderson, D. J. (2002) · Cell · doi:10.1016/s0092-8674(02)00757-2 · Cited by 658 · cited 1×
“nerves result in arteries with misrouted axons (37).”
BackgroundPathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation
Baluk, P., Tammela, T., Ator, E., Lyubynska, N., Achen, M. G., Hicklin, D. J., Jeltsch, M., Petrova, T. V., Pytowski, B., Stacker, S. A., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522037 · Cited by 597
Molecular mechanisms of cancer pain
Mantyh, P. W., Clohisy, D. R., Koltzenburg, M., & Hunt, S. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc747 · Cited by 477
Vascular Growth Factors and Lymphangiogenesis
Jussila, L., & Alitalo, K. (2002) · Physiological Reviews · doi:10.1152/physrev.00005.2002 · Cited by 443
Axon Guidance Molecules in Vascular Patterning
Adams, R. H., & Eichmann, A. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001875 · Cited by 405 · cited 1×
“structure, the axonal growth cone (39).”
Cited by
Cellular and molecular mechanisms of skin wound healing
Peña, O. A., & Martin, P. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00715-1 · Cited by 1,655
“…that might mediate lymphangiogenesis have been reported, including prostaglandin E 2 receptors EP3 and EP4 and receptor activity-modifying protein 1 (RAMP1) 164,165 , but the most convincing mediators of lymphatic vessel sprouting are VEGF receptor 3 (VEGFR3) and its ligands VEGFC and VEGFD.”
Nociceptor Sensory Neuron–Immune Interactions in Pain and Inflammation
Pinho-Ribeiro, F. A., Verri, W. A., & Chiu, I. M. (2017) · Trends in Immunology · doi:10.1016/j.it.2016.10.001 · Cited by 1,027
“The CGRP receptor RAMP1 is necessary for proper angiogenesis and lymphangiogenesis during skin wound healing, and regulates VEGF production [71].”
Neuronal regulation of immunity: why, how and where?
Schiller, M., Ben-Shaanan, T. L., & Rolls, A. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-020-0387-1 · Cited by 264
Receptor Activity-Modifying Proteins (RAMPs): New Insights and Roles
Hay, D. L., & Pioszak, A. A. (2016) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010715-103120 · Cited by 190
In vivo reprogramming of wound-resident cells generates skin epithelial tissue
Kurita, M., Araoka, T., Hishida, T., O’Keefe, D. D., Takahashi, Y., Sakamoto, A., Sakurai, M., Suzuki, K., Wu, J., Yamamoto, M., et al. (2018) · Nature · doi:10.1038/s41586-018-0477-4 · Cited by 148
Okizaki, S.-I., Ito, Y., Hosono, K., Oba, K., Ohkubo, H., Amano, H., Shichiri, M., & Majima, M. (2014) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2014.10.020 · Cited by 161
Self-citationThe Activity of Peptides of the Calcitonin Family in Bone
Naot, D., Musson, D. S., & Cornish, J. (2019) · Physiological Reviews · doi:10.1152/physrev.00066.2017 · Cited by 141
“A study that may have relevance to bone, and specifically to fracture healing, examined wound healing in Ramp1 KO mice (128).”
BackgroundCutaneous innervation in impaired diabetic wound healing
Nowak, N. C., Menichella, D. M., Miller, R. J., & Paller, A. S. (2021) · Translational research · doi:10.1016/j.trsl.2021.05.003 · Cited by 154
McIlvried, L. A., Atherton, M. A., Horan, N. L., Goch, T. N., & Scheff, N. N. (2022) · Advanced Biology · doi:10.1002/adbi.202200019 · Cited by 140
Hyaluronic Acid-Based Nanosystems for CD44 Mediated Anti-Inflammatory and Antinociceptive Activity
Salathia, S., Gigliobianco, M. R., Casadidio, C., Martino, P. D., & Censi, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087286 · Cited by 114
Chronic Pain in Musculoskeletal Diseases: Do You Know Your Enemy?
Bonanni, R., Cariati, I., Tancredi, V., Iundusi, R., Gasbarra, E., & Tarantino, U. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11092609 · Cited by 108
“It also plays an important role as an inducer of angiogenesis and lymphangiogenesis [93].”
BackgroundCalcitonin and Bone Physiology: In Vitro, In Vivo, and Clinical Investigations
Xie, J., Guo, J., Kanwal, Z., Wu, M., Lv, X., Ibrahim, N. A., Li, P., Buabeid, M. A., Arafa, E. A., & Sun, Q. (2020) · International Journal of Endocrinology · doi:10.1155/2020/3236828 · Cited by 83
Bench-to-bedside pharmacology of adrenomedullin
Kato, J., & Kitamura, K. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.06.061 · Cited by 79
“Angiogenesis in RAMP1 knockout mice was characterized by Kurashige et al. (2014), who showed suppressed or delayed angiogenesis by deletion of the gene of this receptor component.”
BackgroundOkizaki, S.-I., Ito, Y., Hosono, K., Oba, K., Ohkubo, H., Kojo, K., Nishizawa, N., Shibuya, M., Shichiri, M., & Majima, M. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.02.014 · Cited by 69
Self-citationElucidating the Interactome of G Protein-Coupled Receptors and Receptor Activity-Modifying Proteins
Kotliar, I. B., Lorenzen, E., Schwenk, J. M., Hay, D. L., & Sakmar, T. P. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000180 · Cited by 56
“A, VEGF-C, and VEGFR-3 and suppressed formation of lymphatic vessels for draining interstitial fluids (Kurashige et al., 2014).”
BackgroundInvolvement of neuronal factors in tumor angiogenesis and the shaping of the cancer microenvironment
Shalabi, S., Belayachi, A., & Larrivée, B. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1284629 · Cited by 54
Hosono, K., Isonaka, R., Kawakami, T., Narumiya, S., & Majima, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162532 · Cited by 50
Self-citationSerafín, D., Harris, N. R., Nielsen, N. R., Mackie, D. I., & Caron, K. M. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.01.009 · Cited by 44
“These studies consistently show that RAMPs play essential roles in the cardiovascular, lymphatic, immune, endocrine, and central and peripheral nervous systems [38-44].”
BackgroundRAMP1 signaling in immune cells regulates inflammation-associated lymphangiogenesis
Tsuru, S., Ito, Y., Matsuda, H., Hosono, K., Inoue, T., Nakamoto, S., Kurashige, C., Mishima, T., Tsujikawa, K., Okamoto, H., et al. (2020) · Laboratory Investigation · doi:10.1038/s41374-019-0364-0 · Cited by 46
Self-citationRAMP1 signaling improves lymphedema and promotes lymphangiogenesis in mice
Mishima, T., Ito, Y., Nishizawa, N., Amano, H., Tsujikawa, K., Miyaji, K., Watanabe, M., & Majima, M. (2017) · Journal of Surgical Research · doi:10.1016/j.jss.2017.05.124 · Cited by 37
Self-citationDeng, T., Yang, L., Zheng, Z., Li, Y., Ren, W., Wu, C., & Guo, L. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7779 · Cited by 34
“It is reported that CGRP has an important role in inflammatory cytokine secretion mediated by s in macrophage (9,10).”
CGRP/CGRP Receptor Antibodies: Potential Adverse Effects Due to Blockade of Neovascularization?
Majima, M., Ito, Y., Hosono, K., & Amano, H. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.11.003 · Cited by 34
Self-citationIwamiya, T., Ségard, B.-D., Matsuoka, Y., & Imamura, T. (2020) · PLoS ONE · doi:10.1371/journal.pone.0237810 · Cited by 33
Yan, W., Liu, H., Deng, X., Jin, Y., Wang, N., & Chu, J. (2017) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2564 · Cited by 31
“Angiogenesis in the granulation tissue is also indispensable for healing of surgical wound (Kamoshita et al., 2006; Kurashige et al., 2014).”
BackgroundAn Evidence-Based Review of Fremanezumab for the Treatment of Migraine
Urits, I., Clark, G., An, D., Wesp, B., Zhou, R. Z., Amgalan, A., Berger, A. A., Kassem, H., Ngo, A. L., Kaye, A. D., et al. (2020) · Pain and Therapy · doi:10.1007/s40122-020-00159-3 · Cited by 34
RAMP1 suppresses mucosal injury from dextran sodium sulfate‐induced colitis in mice
Kawashima‐Takeda, N., Ito, Y., Nishizawa, N., Kawashima, R., Tanaka, K., Tsujikawa, K., Watanabe, M., & Majima, M. (2016) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13505 · Cited by 27
Self-citationHattori, K., Ito, Y., Honda, M., Sekiguchi, K., Hosono, K., Shibuya, M., Unno, N., & Majima, M. (2020) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2020.05.003 · Cited by 27
Self-citationYin, S., Song, R., Ma, J., Liu, C., Wu, Z., Cao, G., Liu, J., Zhang, G. K., Zhang, H., Sun, R. X., et al. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-022-00852-0 · Cited by 28
“RAMP1 was reported to promote wound healing by increasing angiogenesis and lymphangiogenesis [20], suggesting that CGRP function can be modulated by manipulating RAMP1.”
BackgroundThe role of vascular and lymphatic networks in bone and joint homeostasis and pathology
Huang, J., Liao, C., Yang, J., & Zhang, L. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1465816 · Cited by 28
Honda, M., Ito, Y., Hattori, K., Hosono, K., Sekiguchi, K., Tsujikawa, K., Unno, N., & Majima, M. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15823 · Cited by 27
Self-citationRAMP1 in Kupffer cells is a critical regulator in immune-mediated hepatitis
Inoue, T., Ito, Y., Nishizawa, N., Eshima, K., Kojo, K., Otaka, F., Betto, T., Yamane, S., Tsujikawa, K., Koizumi, W., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0200432 · Cited by 24
Self-citationGhosh, S. K., Zheng, M., He, J., Wu, Y., Zhang, Y., Wang, W., Shen, J., Yeung, K., Neelakantan, P., Xu, C., et al. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122908 · Cited by 27
Ben-Shaanan, T. L., Knöpper, K., Duan, L., Liu, R., Taglinao, H., Xu, Y., An, J., Plikus, M. V., & Cyster, J. G. (2024) · Developmental Cell · doi:10.1016/j.devcel.2024.05.019 · Cited by 27
“In wounded skin, CGRP has been associated with stimulating angiogenesis 18 and the proliferation and migration of keratinocytes 19 .”
BackgroundCui, Q., Zheng, X., Bai, Y., Guo, Y., Liu, S., Lu, Y., Liu, L., Song, J., Liu, Y., Heng, B. C., et al. (2024) · Advanced Science · doi:10.1002/advs.202414278 · Cited by 33
Neuro-immune-metabolism: The tripod system of homeostasis
Deshpande, D., Fuchs, L., & Klose, C. S. N. (2021) · Immunology Letters · doi:10.1016/j.imlet.2021.10.001 · Cited by 21
The effects of RAMPs upon cell signalling
Routledge, S. J., Ladds, G., & Poyner, D. R. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.03.033 · Cited by 17
“In an investigation into skin wound healing, RAMP1 (-/-) mice displayed reduced wound-induced angiogenesis and lymphangiogenesis and their ability to heal wounds was decreased compared to WT mice [64].”
Matsui, S., Tanaka, M., Kamiyoshi, A., Sakurai, T., Ichikawa‐Shindo, Y., Kawate, H., Dai, K., Cui, N., Wei, Y., Tanaka, M., et al. (2019) · American Journal Of Pathology · doi:10.1016/j.ajpath.2019.08.011 · Cited by 17
Flow-oriented Venous Anastomosis to Control Lymph Flow of Lymphatic Malformation
Kato, M., Watanabe, S., Watanabe, A., & Iida, T. (2019) · Plastic & Reconstructive Surgery Global Open · doi:10.1097/gox.0000000000002199 · Cited by 15
Kato, M., Watanabe, S., Iida, T., Watanabe, A., & Furuya, M. (2017) · Journal of Pediatric Surgery Case Reports · doi:10.1016/j.epsc.2017.05.008 · Cited by 13
Sustained Activation of CLR/RAMP Receptors by Gel-Forming Agonists
Chang, C. L., Cai, Z. P., & Hsu, S. Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113408 · Cited by 12
Decoding the neuroimmune axis in colorectal cancer: From neural circuitry to therapeutic innovation
Li, Y., Yang, S.-Y., Zhang, Y.-R., & Wang, Y. (2025) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2025.04.001 · Cited by 10
Song, R., Ma, J., Yin, S., Wu, Z., Liu, C., Sun, R., Cao, G., Lu, Y., Liu, J., Su, L., et al. (2025) · Burns & Trauma · doi:10.1093/burnst/tkae068 · Cited by 11
Biologically active lipids in the regulation of lymphangiogenesis in disease states
Majima, M., Hosono, K., Ito, Y., & Amano, H. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.108011 · Cited by 11
Self-citationHosono, K., Yamashita, A., Tanabe, M., Ito, Y., Majima, M., Tsujikawa, K., & Amano, H. (2023) · In Vivo · doi:10.21873/invivo.13422 · Cited by 13
“We have previously shown that CGRP/RAMP1 is responsible for the development of lymphatic vessels in mice with skin wounds (18), endometriosis (19), and secondary lymphedema (20).”
BackgroundSelf-citationZhang, Q., Guo, Y., Chen, H., Jiang, Y., Tang, H., Gong, P., & Xiang, L. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28292 · Cited by 9
“Kurashige's group reported that CGRP‐ RAMP1 signaling upregulated angiogenesis by inducing VEGF expression.(21) Others have also suggested that CGRP‐RAMP1 may increase VEGF secretion, thereby contributing to vascular system remodeling.”
BackgroundResultInfluentialCalcitonin receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database
Hay, D. L., Poyner, D. R., & Walker, C. S. (2019) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f11/2019.4 · Cited by 6
Yamashita, T., Kaplan, U., Chakraborty, A., Marden, G., Gritli, S., Roh, D. S., Bujor, A. M., Trojanowski, M. A., Ligresti, G., Browning, J. L., et al. (2024) · Arthritis & Rheumatology · doi:10.1002/art.42944 · Cited by 5
“32 In whole mount images of lymph nodes, there was a signi fi cant reduction of fl uorescein intensity in ProxErgCKO mice, suggesting either de fi cient lymphatic vessel function or altered lymphatic vessel architecture in these mice (Figure 6B and C).”
Interactions neuro-immunes dans la peau: Un lien entre douleur et immunité
Debroas, G., Hoeffel, G., Reynders, A., & Ugolini, S. (2018) · médecine/sciences · doi:10.1051/medsci/20183405016 · Cited by 7
Dual Factor-Loaded Artificial Periosteum Accelerates Bone Regeneration
Yao, M., Liang, S., Zeng, Y., Peng, F., Zhao, X., Du, C., Ma, X., Huang, H., Wang, D., & Zhang, Y. (2024) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.3c01587 · Cited by 6
Pollack, B. L., Torrisi, J. S., Hespe, G. E., Ashokan, G., Shin, J., Mehrara, B. J., & Kataru, R. P. (2025) · Biomedicines · doi:10.3390/biomedicines13051026 · Cited by 5
“…with other histological studies demonstrating that lymphangiogenesis occurs concomitantly with angiogenesis in the normal wound healing process [48–50] and that states such as venous insu ffi ciency, which can exacerbate chronic wounds, coincide with concomitantly angiogenesis in the normal…”
Hu, R., Lou, Y., Wang, L., He, W., Ma, X., Li, X., & Yue, Z. (2026) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-026-06090-8 · Cited by 4
“Moreover, CGRP binds to its receptors on macrophages such as the CLR and RAMP1 complex [76], triggering intracellular signaling cascades that amplify the expression of genes associated with alternative activation and tissue repair, thereby fostering an environment that supports healing and…”
The effect of pramlintide, an antidiabetic amylin analogue, on angiogenesis-related markers in vitro
Safaeian, L., Vaseghi, G., Mirian, M., & Firoozabadi, M. (2020) · Research in Pharmaceutical Sciences · doi:10.4103/1735-5362.293510 · Cited by 4
Ramírez-Expósito, M. J., Cueto‐Ureña, C., & Martínez-Martos, J. M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27114973 · Cited by 5
“Furthermore, CGRP promotes apoptosis of neutrophils and macrophages in injured tissues, facilitating early clearance of proinflammatory cells and accelerating the transition to the repair phase [69,72,73,75].”
Gel-forming antagonist provides a lasting effect on CGRP-induced vasodilation
Chang, C. L., Cai, Z. P., & Hsu, S. Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1040951 · Cited by 3
Crosstalk between hemostasis and lymphangiogenesis
Suzuki‐Inoue, K., Tsukiji, N., & Otake, S. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14726 · Cited by 3
Cabral, G. D. C., Rodrigues, L. A., Candiago, J. D. A. C., Procópio, J. F. F. F., Silva, J. L. L., de Lima, M. E. B., Lima, A. S. G. E. C., Júnior, J. V. F. D. C., de Araújo, D. A. S., da Silva, J. P. E., et al. (2026) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-026-02021-3 · Cited by 2
“…- nents situating GPCRs/RAMP complexes within modules In RAMP1-deficient mice, wound-induced angiogenesis and lymphangiogenesis were impaired, accompanied by reduced expression of VEGF-A, VEGF-C and VEGFR-3, as well as defective lymphatic vessel formation and diminished interstitial drainage [12 ].”
Calcitonin receptors in GtoPdb v.2023.1
Garelja, M. L., Hay, D. L., Poyner, D. R., & Walker, C. S. (2023) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f11/2023.1 · Cited by 3
Calcitonin receptors in GtoPdb v.2021.2
Hay, D. L., Poyner, D. R., & Walker, C. S. (2021) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f11/2021.2 · Cited by 1
Nakamoto, S., Ito, Y., Nishizawa, N., Kuroda, Y., Hosono, K., Kamata, M., Tsujikawa, K., Kumamoto, Y., & Amano, H. (2024) · In Vivo · doi:10.21873/invivo.13691
“An in vitro study demonstrated that CGRP enhances VEGF-C in cultured bone marrow-derived macrophages (29) and peritoneal macrophages (18) in a RAMP signaling-dependent manner.”
Self-citationYin, S., Song, R., Ma, J., Liu, C., Wu, Z., Cao, G., Liu, J., Zhang, G., Zhang, H., Sun, R., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19588752
Yin, S., Song, R., Ma, J., Liu, C., Wu, Z., Cao, G., Liu, J., Zhang, G., Zhang, H., Sun, R., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19588761
Yin, S., Song, R., Ma, J., Liu, C., Wu, Z., Cao, G., Liu, J., Zhang, G., Zhang, H., Sun, R., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19588755
Ye, M., Li, N., Cai, H., Shi, Y., Sun, H., Kusumbe, A. P., & Chen, J. (2026) · Science China Life Sciences · doi:10.1007/s11427-025-3209-x
“The findings revealed that reduced levels of VEGF-A and VEGF-C in the granulation tissues of RAMP1-knockout mice impaired angiogenesis and lymphangiogenesis, ultimately delaying tissue repair (Kurashige et al., 2014).”
Régulation de la réponse immunitaire de la peau par le système nerveux sensoriel
Debroas, G. (2018) · theses.fr (ABES) · doi:10.70675/bbd33cc0z0f39z452bz9280zf155dc684d0f
Remoué, N. (2020) · theses.fr (ABES) · doi:10.70675/c389889ez096bz463fz8e39zba23faee7939 · Cited by 3
Endothelial system dysregulation underlies keloid development and therapeutic targeting
Yu, Y., Zhu, J., Ma, L., Zhang, X., & Yan, H. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1919403 · Cited by 1
“…and receptor activity-modifying protein 1 (RAMP1), have been reported as potential mediators of lymphangiogenesis; however, the most widely recognized mediators of lymphatic sprouting remain VEGF receptor 3 (VEGFR3) and its ligands VEGF-C and VEGF-D (Kurashige et al., 2014; Hosono et al., 2016).”
Metadata
- Authors
- Kurashige, C., Hosono, K., Matsuda, H., Tsujikawa, K., Okamoto, H., & Majima, M.
- Affiliations
- Kitasato University Hospital (JP)
- Kitasato University (JP)
- The University of Osaka (JP)
- Corresponding author
- Majima, Masataka
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2013-12-05
- Volume
- 28
- Issue
- 3
- Pages
- 1237-1247
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2156179708
- Semantic Scholar
- 83ea945b1fa6d510c894123338adf424d5700576
- Cited by
- 67
- References
- 44
- Citations by year
- 2026: 5 · 2025: 2 · 2024: 10 · 2023: 3 · 2022: 9 · 2021: 4 · 2020: 11 · 2019: 3 · 2018: 7 · 2017: 6 · 2016: 4 · 2015: 2 · 2014: 1
- FWCI
- 2.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (22116001, 25860192, 24659119)
- Topics
- Health Sciences › Medicine › Surgery › Wound Healing and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Keywords
- RAMP1, calcitonin receptor-like receptor, calcitonin gene-related peptide, angiogenesis, lymphangiogenesis, skin wound healing, VEGF-A, VEGF-C, VEGFR-3, macrophages, endothelial cells, bone marrow chimeras
- MeSH terms
- Animals, Base Sequence, Skin, Wound Healing, DNA Primers, Neovascularization, Physiologic, Lymphangiogenesis, Mice, Receptor Activity-Modifying Protein 1, Real-Time Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.